Cargando…
Peptidylarginine deiminase 4 deficiency in bone marrow cells prevents plaque progression without decreasing atherogenic inflammation in apolipoprotein E-knockout mice
INTRODUCTION: Despite multiple studies in the past, the role of peptidylarginine deiminase 4 (PAD4) in atherosclerosis is currently insufficiently understood. In this regard, PAD4 deletion or inhibition of enzymatic activity was previously reported to ameliorate disease progression and inflammation....
Autores principales: | Paunel-Görgülü, Adnana, Conforti, Andreas, Mierau, Natalia, Zierden, Mario, Xiong, Xiaolin, Wahlers, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709396/ https://www.ncbi.nlm.nih.gov/pubmed/36465436 http://dx.doi.org/10.3389/fcvm.2022.1046273 |
Ejemplares similares
-
Impaired non‐canonical transforming growth factor‐β signalling prevents profibrotic phenotypes in cultured peptidylarginine deiminase 4‐deficient murine cardiac fibroblasts
por: Akboua, Hanane, et al.
Publicado: (2021) -
Neutrophil extracellular traps modulate inflammatory markers and uptake of oxidized LDL by human and murine macrophages
por: Conforti, Andreas, et al.
Publicado: (2021) -
Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization
por: Philipp, Denise, et al.
Publicado: (2018) -
The Secretome of Preconditioned Mesenchymal Stem Cells Drives Polarization and Reprogramming of M2a Macrophages toward an IL-10-Producing Phenotype
por: Holthaus, Michelle, et al.
Publicado: (2022) -
Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice
por: Suzuki, Akari, et al.
Publicado: (2016)